Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 86: 1626-1631, 1999;
8750-7587/99 $5.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coker, R. H.
Right arrow Articles by Wasserman, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coker, R. H.
Right arrow Articles by Wasserman, D. H.
Vol. 86, Issue 5, 1626-1631, May 1999

Splanchnic glucagon kinetics in exercising alloxan-diabetic dogs

Robert H. Coker1, D. Brooks Lacy2, Mahesh G. Krishna1, and David H. Wasserman1

1 Department of Molecular Physiology and Biophysics, and 2 The Diabetes Research and Training Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0615

The purpose of this study was to define the relationship between arterial immunoreactive glucagon (IRG) and IRG that perfuses the liver via the portal vein during exercise in the diabetic state. Dogs underwent surgery >16 days before the experiment, at which time flow probes were implanted in the portal vein and the hepatic artery, and Silastic catheters were inserted in the carotid artery, portal vein, and hepatic vein for sampling. Dogs were made diabetic with alloxan injected intravenously ~3 wk before study (AD) or were studied in the nondiabetic state (ND). Each study consisted of a 30-min basal period and a 150-min moderate-exercise period on a treadmill. The findings from these studies indicate that the exercise-induced increment in portal vein IRG can be substantially greater in AD compared with ND, even when arterial and hepatic vein increments are not different. The larger IRG gradient from the portal vein to the systemic circulation in AD dogs is a function of a twofold greater increase in nonhepatic splanchnic IRG release and a fivefold greater hepatic fractional IRG extraction during exercise. In conclusion, during exercise, arterial IRG concentrations greatly underestimate the IRG levels to which the liver is exposed in ND, and this underestimation is considerably greater in dogs with poorly controlled diabetes.

diabetes; portal vein; glucose; liver


This article has been cited by other articles:


Home page
 DiabetesHome page
R. H. Coker, Y. Koyama, J. C. Denny, R. C. Camacho, D. B. Lacy, and D. H. Wasserman
Prevention of Overt Hypoglycemia During Exercise: Stimulation of Endogenous Glucose Production Independent of Hepatic Catecholamine Action and Changes in Pancreatic Hormone Concentration
Diabetes, May 1, 2002; 51(5): 1310 - 1318.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. H. Coker, L. Simonsen, J. Bulow, D. H. Wasserman, and M. Kjar
Stimulation of splanchnic glucose production during exercise in humans contains a glucagon-independent component
Am J Physiol Endocrinol Metab, June 1, 2001; 280(6): E918 - E927.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. H. Coker, D. B. Lacy, P. E. Williams, and D. H. Wasserman
Hepatic alpha - and beta -adrenergic receptors are not essential for the increase in Ra during exercise in diabetes
Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E444 - E451.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. H. Coker, Y. Koyama, D. B. Lacy, P. E. Williams, N. Rheaume, and D. H. Wasserman
Pancreatic innervation is not essential for exercise-induced changes in glucagon and insulin or glucose kinetics
Am J Physiol Endocrinol Metab, December 1, 1999; 277(6): E1122 - E1129.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online